PMID: 1120290Jan 1, 1975Paper

Metabolism distribution, and disappearance of injected beta-phenylethylamine in the rat

Canadian Journal of Biochemistry
P H Wu, A A Boulton

Abstract

In the absence of a monoamine oxidase inhibitor, the bulk of intravenously injected radioactively labelled beta-phenylethylamine was oxidized to phenylacetic acid. In the presence of pargyline, most of the label in tissues remained as unchanged phenylethylamine; small amounts of labelled phenylethanolamine, tyramine and octopamine were also identified. After intravenous injection of [14-C]phenylalanine, only very small amounts of [14-C] phenylethylamine could be located in urine and faeces. Beta-Phenylethylamine became concentrated in all tissues, including brain, following intravenous introduction both in the presence and absence of pargyline. Its clearance from these tissues and from brain regions was very fast.

Citations

Jan 1, 1984·Psychopharmacology·A J Greenshaw, C T Dourish
Apr 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·O E UkponmwanM Dzoljic
Sep 1, 1989·Cellular and Molecular Neurobiology·T V Nguyen, A V Juorio
Oct 1, 1988·Neurochemical Research·D A DurdenA A Boulton
Jun 15, 1994·Biochemical Pharmacology·B L GoodwinM Sandler
Feb 22, 1996·European Journal of Pharmacology·N Barroso, M Rodriguez
Jun 1, 1977·Pharmacology, Biochemistry, and Behavior·M E Risner, B E Jones
Jan 1, 1984·Pharmacology, Biochemistry, and Behavior·S J Cooper, C T Dourish
Dec 1, 1985·Pharmacology, Biochemistry, and Behavior·T M Smith
Nov 1, 1989·Psychiatry Research·K F FaullJ G Csernansky
Jan 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·R L O'Reilly, B A Davis
Jan 1, 1989·General Pharmacology·A D MosnaimM E Wolf
Aug 1, 1985·Brain Research Bulletin·A J GreenshawA A Boulton
Feb 1, 1988·Brain Research Bulletin·I A Paterson, A A Boulton
Jan 7, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·G ZhouT Matsuishi
Feb 15, 1983·Experientia·A A Boulton, A V Juorio
Jan 1, 1983·Journal of Neuroscience Research·L E DyckA A Boulton
Oct 1, 1975·Journal of Neurochemistry·A A Boulton, G B Baker
Jun 1, 1982·Journal of Neurochemistry·D A Durden, A A Boulton
Jul 1, 1979·Journal of Neurochemistry·S R Philips, A A Boulton
Jul 8, 2008·British Journal of Pharmacology·A A HerbertK J Broadley
Aug 1, 1978·Biomedical Mass Spectrometry·L E FellowsM Sandler
Oct 1, 1983·The Journal of Pharmacy and Pharmacology·P J Worland, K F Ilett
Sep 15, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·S H AudiD L Roerig
Feb 21, 1979·Journal of Chromatography·N D Huebert, A A Boulton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.